Clinical overview
Amniotic fluid is not inert packing — it is a dynamic, fetally-derived medium that protects the cord and limbs, permits symmetrical musculoskeletal growth and lung development, allows fetal swallowing and breathing movements, and buffers infection. Its volume is the visible end-result of an equilibrium between fetal urine production and lung-fluid efflux (the inflows) and fetal swallowing and intramembranous absorption (the outflows). Because that equilibrium is tightly fetally regulated, an abnormal liquor volume is rarely the disease itself; it is a window onto a problem somewhere in the fetal–placental unit. The registrar's task is therefore never simply to label a measurement as "oligo-" or "poly-", but to ask what the abnormal volume is telling you about uteroplacental function, fetal anatomy, fetal swallowing, fetal urine output, or the membranes.
In a South African public-sector setting this is a high-yield, high-frequency problem. Oligohydramnios most often co-travels with the conditions that dominate our maternal and perinatal mortality picture — pre-eclampsia, fetal growth restriction and post-dates pregnancies — and so its detection feeds directly into surveillance and timing-of-delivery decisions made under real resource constraints. Polyhydramnios, less common, raises the question of undiagnosed maternal diabetes (very prevalent and often missed), fetal structural or swallowing anomalies, and — acutely — the risk of cord prolapse and abruption when the membranes rupture against an over-distended uterus. Getting the assessment and the escalation pathway right matters for the baby.
Core knowledge
Amniotic fluid dynamics
From the second trimester onward, fetal urine is the dominant source of amniotic fluid and fetal swallowing the dominant route of removal, with intramembranous absorption across the fetal surface of the placenta and cord providing the final regulatory step. This explains the two great mechanistic families:
- Reduced inflow → oligohydramnios. Anything that lowers fetal urine output: chronic uteroplacental insufficiency (the FGR/pre-eclampsia axis, where preferential blood-flow redistribution spares brain and heart at the kidneys' expense), renal agenesis or dysplasia, or lower-urinary-tract obstruction (posterior urethral valves) where urine is made but cannot reach the amniotic cavity.
- Lost fluid → oligohydramnios via PPROM — membrane rupture is the single commonest cause of reduced liquor in clinical practice and must always be actively excluded.
- Increased inflow or blocked outflow → polyhydramnios. Either the fetus makes too much urine (maternal hyperglycaemia driving fetal osmotic diuresis; recipient twin in twin–twin transfusion syndrome) or it cannot swallow/absorb the fluid (oesophageal atresia, duodenal atresia, neuromuscular or CNS conditions impairing swallowing, severe anaemia/hydrops).
Definitions and thresholds
Volume is estimated sonographically, not measured directly. Two indices are in routine use, and the registrar should know both because the choice between them changes the diagnosis rate:
- Single deepest pocket (SDP / maximum vertical pocket): a clear, cord-free, fetal-part-free vertical column of fluid. Standard teaching: oligohydramnios = SDP < 2 cm; polyhydramnios = SDP > 8 cm.
- Amniotic fluid index (AFI): the sum of the deepest vertical pocket in each of four uterine quadrants. Standard teaching: oligohydramnios = AFI < 5 cm; polyhydramnios (broadly) = AFI > 24–25 cm, with severity often graded (mild/moderate/severe) by increasing AFI.
A key point repeatedly tested: in the third trimester and in labour, the SDP is preferred because, compared with the AFI, it identifies fewer fetuses as oligohydramnios without worsening perinatal outcome — i.e. AFI over-diagnoses and drives more intervention (induction, caesarean) for no demonstrable benefit. Use the SDP as your working index unless local protocol dictates otherwise, and document which index you used.
Anhydramnios is the complete absence of measurable fluid — a different and more ominous category, classically associated with bilateral renal agenesis, early severe PPROM, or end-stage placental failure.